CIK 0001668243
- Non-accelerated filer
- Smaller reporting company
UroGen Pharma Ltd.
Sign in to watch- Ticker
- URGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- Operating
- Phone
- +972 97707601
- Business address
- 9 HA'TA'ASIYA ST, RA'ANANA, Israel, 4365007
- 4 Open-market sale Chief Medical Officer sold 5,149 shares at $19.14 ($98,552)
- 4 Open-market sale Chief Medical Officer sold 5,162 shares at $7.37 ($38,044)
- 4 Open-market sale Chief Medical Officer sold 4,551 shares at $11.14 ($50,698)
- 4 Open-market sale General Counsel sold 7,379 shares at $11.14 ($82,202)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Chief Medical Officer sold 859 shares at $13.08 ($11,236)
- 4 Open-market sale General Counsel sold 1,521 shares at $13.08 ($19,895)
- 4 Exercise or conversion Chief Financial Officer acquired 2,500 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Medical Officer sold 5,153 shares at $13.08 ($67,401)
- 4 Open-market sale Chief Medical Officer sold 12,000 shares at $14.05 ($168,600)
- 4/A Exercise or conversion Chief Financial Officer acquired 3,333 shares (option exercise)
Page 3 of 12 · 233 filings